Global /United States /Healthcare /Medical Devices /TNDM
chevron_leftBack
Tandem Diabetes Care, Inc. logo

Tandem Diabetes Care, Inc.

TNDM
NASDAQ: TNDM Delayed
18.16USD -2.5%
As of 13 June 2026, Tandem Diabetes Care, Inc. has a market cap of $1.24B USD, ranking #9475 globally and #2023 in the United States. It ranks #813 in the Healthcare sector, and #163 in the Medical Devices industry.
Global Rank
9475
Country Rank
2023
Sector Rank
813
Industry Rank
163
Key Stats
Market Cap
$1.24BUSD
Enterprise Value
$1.4BUSD
Revenue (TTM)
$1.01BUSD
EBITDA (TTM)
-$60.46MUSD
Net Income (TTM)
-$204.71MUSD
EBITDA Margin
-6%
Profit Margin
-20%
PS Ratio
1.2
PB Ratio
8.0
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Devices
CEO
John Sheridan open_in_new
Employees
2,500
Founded
2006
IPO
14 Nov 2013
Website
tandemdiabetes.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-2.5% -9.7% -14% -5.4% 20% 3.5%

News

Loading...

TNDM Analyst Forecasts

Loading...

Markets

Exchange Ticker Price
NASDAQ
MIC: XNAS
PRIMARY
TNDM
Tandem Diabetes Care Inc
ISIN: US8753722037
Shares Out.:
68.529M1 Shares Float: 63.339M2
TV:
SA:
YF:
GF:
NQ:
BA:
MS:
18.16 USD
London Stock Exchange
MIC: XLON
0M0F
Tandem Diabetes Care Inc
ISIN: US8753722037
TV:
SA:
YF:
GF:
BA:
MS:
18.80 USD
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Tandem Diabetes Care, Inc.

Tandem Diabetes Care, Inc. designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. It’s flagship products are the t:slim X2 insulin delivery system; and Tandem Mobi insulin pump, an automated insulin delivery system. The company also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user’s body. In addition, it offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs; and Sugarmate, a mobile app used to help people visualize diabetes therapy data. The company has collaboration agreement with the University of Virginia Center for Diabetes Technology for research and development of fully automated closed-loop insulin delivery systems. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.

Similar Companies

Industry: Medical Devices (United States)
Name
Market Cap diff.
PE
$173.27B
14K%
25.8
$160.73B
13K%
56.7
$159.07B
13K%
25.6
DHR
$126.55B
10K%
34.7
SYK
$120.69B
10K%
38.3
$84.93B
7K%
24.5
Industry: Medical Devices (Global)
Name
Market Cap diff.
PE
MDT
$101.9B
8K%
22.2
$97.46B
84.32B EUR
8K%
36.7
7741
$61.41B
9.83T JPY
5K%
40.0
$45.47B
39.34B EUR
4K%
18.7
ALC
$36.38B
28.99B CHF
3K%
37.9
$30.06B
203.66B CNY
2K%
26.0
chevron_leftBack